European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

EFIM Annual Report 2025

Submitted by Aneta on 26 June 2026 - 11:44

EFIM Annual Report 2025 Published

We are pleased to announce that the EFIM Annual Report 2025 is now available.
The report provides an overview of EFIM’s activities, achievements, and key developments throughout the year.
We invite our national socieities  members, partners, and the wider community to explore the report and learn more about EFIM's initiatives and projects.

Read the full Annual Report here: Annual Report 2025

Human medicines European public assessment report (EPAR): Aujemflu, Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, Status: Opinion

Submitted by Anonymous (not verified) on 26 June 2026 - 11:00

Human medicines European public assessment report (EPAR): Aujemflu, Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, Status: Opinion

Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Status: Opinion

Submitted by Anonymous (not verified) on 26 June 2026 - 11:00

Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Status: Opinion

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More